Intrapartum Glycemic Control and Clinical Outcomes
Authors:
- 1 November 2025
- journal article
- Published by American Diabetes Association in Diabetes Spectrum
- Vol. 38 (4) , 400-406
Abstract
Current recommendations encourage strict intrapartum glycemic control for individuals with diabetes in pregnancy to optimize maternal and neonatal outcomes. However, established evidence is limited in providing a strong association between strict maternal blood glucose control and neonatal outcomes.Keywords
This publication has 43 references indexed in Scilit:
- Neonatal hypoglycemia and neurodevelopmental outcomes: Yesterday, today, tomorrowEuropean Journal of Pediatrics, 2024
- Metabolomic insights into maternal and neonatal complications in pregnancies affected by type 1 diabetesDiabetologia, 2023
- 778: The association between intrapartum maternal glycemic control and neonatal hypoglycemiaAmerican Journal of Obstetrics and Gynecology, 2020
- Moderate neonatal hypoglycemia and adverse neurological development at 2–6 years of ageEuropean Journal of Epidemiology, 2018
- Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 YearsJAMA Pediatrics, 2017
- 526: Intrapartum glycemic control and risk of neonatal hypoglycemiaAmerican Journal of Obstetrics and Gynecology, 2017
- Association Between Transient Newborn Hypoglycemia and Fourth-Grade Achievement Test ProficiencyJAMA Pediatrics, 2015
- Glucose Control during Labor and DeliveryCurrent Diabetes Reports, 2013
- Intrapartum maternal glycemic control in women with insulin requiring diabetes: A randomized clinical trial of rotating fluids versus insulin dripAmerican Journal of Obstetrics and Gynecology, 2006
- Maternal intravenous glucose administration as a cause of hypoglycemia in the infant of the diabetic motherAmerican Journal of Obstetrics and Gynecology, 1972